Back to search
FDAFDA · Food and drugs·Recall number D-1494-2022

CORRECTDOSE Children's COUGH & CHEST CONGESTION DM (Guaifenesin 100 mg / Dextromethorphan 5 mg per 5 mL) 2.04FL. OZ (60mL), packaged in 12-5 individual doses, Distributed by Correct Dose Inc, Braintree MA 02184. NDC 62320-321-05 UPC 8 60003 67146 7

Published September 14, 2022 · Recall initiated: June 7, 2022

Summary

FDA records drug Class II recall D-1494-2022, published September 14, 2022 and initiated June 7, 2022. Recalling firm: Plastikon Healthcare LLC; Status: Terminated; Reported quantity: 1,464 ampoules; Lot: Lot # 21014A, EXP Feb. 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Plastikon Healthcare LLC
Distributor
Distributed Nationwide in the USA
Lot
Lot # 21014A, EXP Feb. 2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CORRECTDOSE Children's COUGH & CHEST CONGESTION DM (Guaifenesin 100 mg / Dextromethorphan 5 mg per 5 mL) 2.04FL. OZ (60mL), packaged in 12-5 individual doses, Distributed by Correct Dose Inc, Braintree MA 02184. NDC 62320-321-05 UPC 8 60003 67146 7 recalled?

Yes. FDA published recall D-1494-2022 on September 14, 2022. Reported hazard: CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit